Laughter Helps Fuel IMF Myeloma Research

Laughter Helps Fuel IMF Myeloma Research

Whoever coined the phrase “laughter is the best medicine” must have had Saturday night’s 11th Annual Comedy Celebration in mind. “The generous donors who participate in this annual event have made a tremendous impact on myeloma research, and we are beginning to see results,” says IMF Chairman Dr. Brian Durie. Proceeds from the IMF’s Comedy Celebration have helped support more than 40 fully-funded myeloma research projects under way at major medical institutions around the world. Read Dr Durie’s blog.​

 

Star-Studded 11th Annual IMF Comedy Celebration: Only 48 hours Away!

This Saturday night, November 4, 2017, catch the star-studded lineup for the IMF 11th Annual Comedy Celebration at the Wilshire Ebell Theatre in Los Angeles. Actor and comedian Ray Romano hosts an evening of eight headliners under one roof. This year, we welcome Hannibal Buress, Rachel Feinstein, Nikki Glaser, Robert Klein, Marc Maron, Kumail Nanjiani, Iliza Shlesinger, and Fred Willard. Only a few tickets are still available.

Watch the 11th Annual IMF Comedy Celebrations Pre-Show Buzz Via Facebook Live

Alie Ward (CBS’ Innovation Nation Correspondent and Ologies Podcast Host) and Daphne Lee (Miss Black USA) will host a live stream of the 11th annual Comedy Celebration red carpet arrivals and silent auction, exclusively from 6 to 8 p.m. PT at facebook.com/myeloma. Once you tune in, make sure to SHARE the live stream to your personal Facebook page to increase myeloma awareness. For the silent auction, you can view all the auction items, and bidding is open online now!

Phase III ARROW Trial of Kyprolis Shows More Effective Dosing Schedule

The randomized, open-label, phase III ARROW trial tested the dosing schedule of Kyprolis® (carfilzomib) in patients with relapsed and refractory myeloma. The trial studied the use of Kyprolis in combination with dexamethasone dosed once-weekly, compared to the use of the same combination dosed twice-weekly. The ARROW trial showed that once-weekly dosing of Kyprolis with dexamethasone, led to an additional 3.6 months of progression-free survival.

Register Now for This ‘Living Well With Myeloma’ Webinar

Join the IMF’s Nurse Leadership Board members, Beth Faiman and Charise Gleason, for this “Living Well With Myeloma” webinar on “How to Talk With Your Healthcare Team About What’s Best for You.” This webinar will introduce patients to shared decision-making. It includes case studies that show how patients and healthcare providers can communicate more successfully.

What may be causing heart and kidney issues in an elderly myeloma patient with no bone lesions?

In this week’s video, Dr. Brian G.M. Durie explains why amyloidosis may occur in some multiple myeloma patients.

This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology